{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:21Z","timestamp":1786982121702,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s11894-023-00914-4","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T06:02:41Z","timestamp":1704434561000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Managing IBD Patients with Concomitant HIV Infection - a Systematic Review"],"prefix":"10.1007","volume":"26","author":[{"given":"Hugo","family":"Sousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Barroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"key":"914_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","volume":"5","author":"S Alatab","year":"2020","unstructured":"Alatab S, Sepanlou SG, Ikuta K, Vahedi H, Bisignano C, Safiri S, et al. The global, regional, and national burden of inflammatory bowel Disease in 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5:17\u201330.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"914_CR2","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","volume":"389","author":"J Torres","year":"2017","unstructured":"Torres J, Mehandru S, Colombel J-F, Peyrin-Biroulet L. Crohn\u2019s Disease. Lancet Lond Engl. 2017;389:1741\u201355.","journal-title":"Lancet Lond Engl"},{"key":"914_CR3","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","volume":"389","author":"R Ungaro","year":"2017","unstructured":"Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel J-F. Ulcerative Colitis. The Lancet. 2017;389:1756\u201370.","journal-title":"The Lancet"},{"key":"914_CR4","unstructured":"Global HIV. & AIDS statistics [Internet]. UNAIDS. 2023 [cited 2023 Feb 21]. Available from: https:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"914_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(18)31311-4","volume":"392","author":"J Ghosn","year":"2018","unstructured":"Ghosn J, Taiwo B, Seedat S, Autran B, Katlama C. HIV Lancet Lond Engl. 2018;392:685\u201397.","journal-title":"HIV Lancet Lond Engl"},{"key":"914_CR6","unstructured":"Global HIV. & AIDS statistics \u2014 Fact sheet [Internet]. [cited 2023 Oct 20]. Available from: https:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"914_CR7","first-page":"337","volume":"28","author":"A Skamnelos","year":"2015","unstructured":"Skamnelos A, Tatsioni A, Katsanos KH, Tsianos V, Christodoulou D, Tsianos EV. CD4 count remission hypothesis in patients with inflammatory bowel Disease and human immunodeficiency virus Infection: a systematic review of the literature. Ann Gastroenterol. 2015;28:337\u201346.","journal-title":"Ann Gastroenterol"},{"key":"914_CR8","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1093\/clinids\/21.5.1282","volume":"21","author":"J Clerinx","year":"1995","unstructured":"Clerinx J, Bogaerts J, Taelman H, Habyarimana JB, Nyirabareja A, Ngendahayo P, et al. Chronic diarrhea among adults in Kigali, Rwanda: association with bacterial enteropathogens, rectocolonic inflammation, and human immunodeficiency virus Infection. Clin Infect Dis off Publ Infect Dis Soc Am. 1995;21:1282\u20134.","journal-title":"Clin Infect Dis off Publ Infect Dis Soc Am"},{"key":"914_CR9","doi-asserted-by":"crossref","unstructured":"Olariu C, Nurciu A. Chronic diarrhea in patients with acquired immunodeficiency syndrome (AIDS). BMC Infect Dis [Internet]. 2014;14. Available from: https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-S4-P20.","DOI":"10.1186\/1471-2334-14-S4-P20"},{"key":"914_CR10","first-page":"e27114","volume":"14","author":"S Kommuru","year":"2022","unstructured":"Kommuru S, Aziz SN, Sagireddy S, Kaur G, Rijal S, Loh CC, et al. Risk factors for Colorectal Cancer in inpatients with Ulcerative Colitis: a nationwide cross-sectional analysis. Cureus. 2022;14:e27114.","journal-title":"Cureus"},{"key":"914_CR11","doi-asserted-by":"publisher","first-page":"640","DOI":"10.14309\/01.ajg.0000707152.21857.ef","volume":"115","author":"R Dalsania","year":"2020","unstructured":"Dalsania R, Nustas R, Patnana S, Brown J, Qayed E. Prevalence of gastrointestinal disorders and their healthcare burden in hospitalized Hiv patients in the United States. Am J Gastroenterol. 2020;115:640\u2013S641.","journal-title":"Am J Gastroenterol"},{"key":"914_CR12","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s10067-020-05500-x","volume":"40","author":"JJ Damba","year":"2021","unstructured":"Damba JJ, Laskine M, Jin Y, Sinyavskaya L, Durand M. Incidence of autoimmune Diseases in people living with HIV compared to a matched population: a cohort study. Clin Rheumatol. 2021;40:2439\u201345.","journal-title":"Clin Rheumatol"},{"key":"914_CR13","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.gastha.2022.08.003","volume":"1","author":"R Elmahdi","year":"2022","unstructured":"Elmahdi R, Kochhar GS, Iversen AT, Allin KH, Dulai PS, Desai A, et al. Development of inflammatory bowel Disease in HIV patients: a Danish cohort study (1983\u20132018) with American validation (1999\u20132018). Gastro Hep Adv. 2022;1:1114\u201321.","journal-title":"Gastro Hep Adv"},{"key":"914_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/00004836-199607000-00008","volume":"23","author":"EM Yoshida","year":"1996","unstructured":"Yoshida EM, Chan NH, Herrick RA, Amar JN, Sestak PM, Willoughby BC, et al. Human immunodeficiency virus Infection, the acquired immunodeficiency syndrome, and inflammatory bowel Disease. J Clin Gastroenterol. 1996;23:24\u20138.","journal-title":"J Clin Gastroenterol"},{"key":"914_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/00042737-199606000-00015","volume":"8","author":"DR Sharpstone","year":"1996","unstructured":"Sharpstone DR, Duggal A, Gazzard BG. Inflammatory bowel Disease in individuals seropositive for the human immunodeficiency virus. Eur J Gastroenterol Hepatol. 1996;8:575\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"914_CR16","doi-asserted-by":"crossref","unstructured":"Siwak E, Suchacz MM, Cielniak I, Kubicka J, Firl\u0105g-Burkacka E, Wierci\u0144ska-Drapa\u0142o A. Inflammatory bowel Disease in adult HIV-Infected Patients-Is sexually transmitted Infections misdiagnosis possible? J Clin Med. 2022;11.","DOI":"10.3390\/jcm11185324"},{"key":"914_CR17","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1097\/QAD.0000000000001603","volume":"31","author":"D Lebrun","year":"2017","unstructured":"Lebrun D, Hentzien M, Cuzin L, Rey D, Joly V, Cotte L, et al. Epidemiology of autoimmune and inflammatory Diseases in a French nationwide HIV cohort. AIDS Lond Engl. 2017;31:2159\u201366.","journal-title":"AIDS Lond Engl"},{"key":"914_CR18","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1097\/MEG.0000000000000891","volume":"29","author":"C B\u00e4hler","year":"2017","unstructured":"B\u00e4hler C, Schoepfer AM, Vavricka SR, Br\u00fcngger B, Reich O. Chronic comorbidities associated with inflammatory bowel Disease: prevalence and impact on healthcare costs in Switzerland. Eur J Gastroenterol Hepatol. 2017;29:916\u201325.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"914_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.5217\/ir.2017.15.1.97","volume":"15","author":"P Harsh","year":"2017","unstructured":"Harsh P, Gupta V, Kedia S, Bopanna S, Pilli S, Surendernath, et al. Prevalence of Hepatitis B, Hepatitis C and human immunodeficiency viral Infections in patients with inflammatory bowel Disease in north India. Intest Res. 2017;15:97\u2013102.","journal-title":"Intest Res"},{"key":"914_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0016-5085(10)60936-5","volume":"138","author":"M Juneja","year":"2010","unstructured":"Juneja M, Schwartz M, El Mourabet M, Dunn MA, Baidoo L, Swoger JM, et al. Patterns of co-morbid Illness and Nutritional Deficiencies in geriatric Crohn\u2019s Disease. Gastroenterology. 2010;138:207.","journal-title":"Gastroenterology"},{"key":"914_CR21","doi-asserted-by":"crossref","unstructured":"Landy J, Gazzard B, Harbord M. Inflammatory bowel Disease in HIV Seropositive individuals: analysis of a large cohort. AGA Abstracts. 2008;A-504.","DOI":"10.1016\/S0016-5085(08)62352-5"},{"key":"914_CR22","doi-asserted-by":"crossref","unstructured":"Guillo L, Uzzan M, Beaugerie L, Gornet J-M, Amiot A, Pelletier A-L et al. Impact of HIV infection on the course of inflammatory bowel disease and drug safety profile: A multicenter GETAID study. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2022;20:787\u2013797.e2.","DOI":"10.1016\/j.cgh.2020.12.023"},{"key":"914_CR23","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1023\/A:1018883112012","volume":"43","author":"D Pospai","year":"1998","unstructured":"Pospai D, Ren\u00e9 E, Fiasse R, Farahat K, Beaugery L, Lammens P, et al. Crohn\u2019s Disease stable remission after human immunodeficiency virus Infection. Dig Dis Sci. 1998;43:412\u20139.","journal-title":"Dig Dis Sci"},{"key":"914_CR24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/ibd.21077","volume":"16","author":"N Viazis","year":"2010","unstructured":"Viazis N, Vlachogiannakos J, Georgiou O, Rodias M, Georgiadis D, Papastamopoulos V, et al. Course of inflammatory bowel Disease in patients infected with human immunodeficiency virus. Inflamm Bowel Dis. 2010;16:507\u201311.","journal-title":"Inflamm Bowel Dis"},{"key":"914_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.12691\/ajmcr-7-8-3","volume":"7","author":"F Arroyo-Mercado","year":"2019","unstructured":"Arroyo-Mercado F, Likhtshteyn M, Huynh CD, Chokshi T, Chawla GS, Grossman E, et al. CD4 levels and viral load during Ulcerative Colitis flares in patients with human immunodeficiency virus: a Case Series. Am J Med Case Rep. 2019;7:162\u20136.","journal-title":"Am J Med Case Rep"},{"key":"914_CR26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ibd.22966","volume":"19","author":"M Abramowitz","year":"2013","unstructured":"Abramowitz M, Ramachandran R, Koczka C, Lawlor G. Human immunodeficiency virus: CD4 count does not impact ulcerative Colitis relapse risk. Inflamm Bowel Dis. 2013;19:54.","journal-title":"Inflamm Bowel Dis"},{"key":"914_CR27","doi-asserted-by":"crossref","unstructured":"Calafat Sard M, S\u00faria C, Mesonero F, de Francisco R, Yag\u00fce Caballero C, de la Pe\u00f1a L et al. DOP17 HIV infection is associated with a less aggressive phenotype of inflammatory bowel disease. A multicenter study based on the ENEIDA registry. J Crohns Colitis. 2023;17:i80\u20131.","DOI":"10.1093\/ecco-jcc\/jjac190.0057"},{"key":"914_CR28","doi-asserted-by":"crossref","unstructured":"Then E, Uhlenhopp DJ, Barakat M, John F, Gayam V, Lopez M et al. The impact of human immunodeficiency virus (HIV) on inflammatory bowel disease (IBD): A retrospective nationwide study. Curr HIV Res. 2021;19:411\u20139.","DOI":"10.2174\/1570162X19666210611145635"},{"key":"914_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0016-5085(16)30267-0","volume":"150","author":"TH Ho","year":"2016","unstructured":"Ho TH, Fausel R, Yang J, Swartz T, Torres J, Aberg J, et al. The impact of concurrent HIV-1 Infection on the management of patients with inflammatory bowel Disease. Gastroenterology. 2016;150:42.","journal-title":"Gastroenterology"},{"key":"914_CR30","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/ofid\/ofab466.1021","volume":"8","author":"TJ Hunt","year":"2021","unstructured":"Hunt TJ, Kozuch PL, Spacek LA. Immunosuppressive Agent Use in patients with Comorbid HIV and Inflammatory Bowel Disease. Open Forum Infect Dis. 2021;8:505.","journal-title":"Open Forum Infect Dis"},{"key":"914_CR31","doi-asserted-by":"publisher","first-page":"500","DOI":"10.14309\/00000434-201410002-01693","volume":"109","author":"M Abramowitz","year":"2014","unstructured":"Abramowitz M, Ramachandran R, Koczka C, Lawlor G. CD4 count does not impact Disease severity in HIV positive patients with ulcerative Colitis. Am J Gastroenterol. 2014;109:500\u20131.","journal-title":"Am J Gastroenterol"},{"key":"914_CR32","doi-asserted-by":"publisher","first-page":"485","DOI":"10.18433\/J3GG6D","volume":"17","author":"RM Nanau","year":"2014","unstructured":"Nanau RM, Cohen LB, Neuman MG. Risk of Infections of biological therapies with accent on inflammatory bowel Disease. J Pharm Pharm Sci. 2014;17:485\u2013528.","journal-title":"J Pharm Pharm Sci"},{"key":"914_CR33","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/QAD.0000000000000121","volume":"28","author":"FE Chamberlain","year":"2014","unstructured":"Chamberlain FE, Dinani N, Jagjit Singh GK, Bower M, Nelson M. Azathioprine can be safely used in HIV-infected individuals. AIDS Lond Engl. 2014;28:447\u20138.","journal-title":"AIDS Lond Engl"},{"key":"914_CR34","doi-asserted-by":"crossref","unstructured":"Uzzan M, Tokuyama M, Rosenstein AK, Tomescu C, SahBandar IN, Ko HM et al. Anti-\u03b14\u03b27 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals. Sci Transl Med. 2018;10.","DOI":"10.1126\/scitranslmed.aau4711"},{"key":"914_CR35","first-page":"260","volume":"35","author":"J Schwartz","year":"2022","unstructured":"Schwartz J, Stein DJ, Feuerstein JD. Comprehensive National Inpatient Sample data reveals low but rising pneumocystis jiroveci Pneumonia risk in inflammatory bowel Disease patients. Ann Gastroenterol. 2022;35:260\u20136.","journal-title":"Ann Gastroenterol"},{"key":"914_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11926-016-0572-1","volume":"18","author":"S Vallabhaneni","year":"2016","unstructured":"Vallabhaneni S, Chiller TM. Fungal Infections and New Biologic therapies. Curr Rheumatol Rep. 2016;18:29.","journal-title":"Curr Rheumatol Rep"},{"key":"914_CR37","doi-asserted-by":"crossref","unstructured":"Lambert Jl. w., Segaert S, Ghislain Pd, Hillary T, Nikkels A, Willaert F et al. Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 2). J Eur Acad Dermatol Venereol. 2020;34:1914\u201323.","DOI":"10.1111\/jdv.16683"},{"key":"914_CR38","unstructured":"Nakamura M, Abrouk M, Farahnik B, Zhu TH, Bhutani T. Psoriasis treatment in HIV-positive patients: a systematic review of systemic immunosuppressive therapies. Cutis. 2018;101:38;42;56."},{"key":"914_CR39","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","volume":"13","author":"C Maaser","year":"2019","unstructured":"Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of Complications. J Crohns Colitis. 2019;13:144\u2013164K.","journal-title":"J Crohns Colitis"},{"key":"914_CR40","unstructured":"Ca C, Rk C, Ac MK. B. Monitoring Patients With Inflammatory Bowel Disease at High Risk of Anal Cancer. Am J Gastroenterol [Internet]. 2023 [cited 2023 Dec 26]; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37721307\/."},{"key":"914_CR41","doi-asserted-by":"crossref","unstructured":"Field J, Fenton C, Zhang L, Brickman C, Mahadevan U. Inflammatory bowel Disease and the risk of anal squamous Intraepithelial lesions and Anal Cancer in men who have sex with men. Inflamm Bowel Dis. 2023;izad266.","DOI":"10.1093\/ibd\/izad266"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-023-00914-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11894-023-00914-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-023-00914-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T09:11:27Z","timestamp":1706001087000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11894-023-00914-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["914"],"URL":"https:\/\/doi.org\/10.1007\/s11894-023-00914-4","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"29 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Sousa has nothing to disclose. Dr. Barroso has nothing to disclose. Dr. Tavares has nothing to disclose. Professor Torres has received ad board and\/or speaker fees from Abbvie, Janssen, Pfizer, Tillots and Sandoz.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}}]}}